The second-generation ALK inhibitor alectinib induces apoptosis in both ALK wild-type and ALK mutant NB cells, and it is even more effective when combined with HDAC inhibitor vorinostat (Table 2) [113]. The gene discussed is ALK; the disease is neuroblastoma.